Mass.-based Moderna could be first to manufacture bird flu vaccine
A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...
S&P 500 Gains and Losses Today: Moderna Stock Plunges After Analyst Downgrade
The S&P 500 fell 0.5% on Wednesday, Jan. 29, as the Federal Reserve held interest rates steady in a move widely expected by ...
Herald Series8d
Moderna says government has shown 'commitment to growth'
Vaccine manufacturer Moderna has welcomed the Chancellor's announcements regarding major infrastructure schemes.
A norovirus vaccine could be on the horizon as cases rise
Moderna is testing a norovirus vaccine in a phase three trial. Results could be available as soon as this year.
The Economist14d
What a buzzy startup reveals about Britain’s biotech sector
Quotient Therapeutics, a biotech company founded in 2022, hopes to take this transatlantic model and commercialise it. Its main research lab is in Great Chesterford, a village just outside Cambridge, ...
Bird Flu: US Invests $590 Million to Fast-Track Vaccine Development
The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.
Seeking Alpha18d
Despite Setbacks, Moderna Sees Opportunity In Avian Flu, Merck Partnership
Moderna's recent stumbles make the company an acquisition target. Merck desperately needs Moderna's mRNA-based Personal Cancer Vaccines ("PCVs") to extend KEYTRUDA's patent protection beyond 2028 ...
Northcountrypublicradio.org18d
U.S. pays $590 million to Moderna to speed up development of bird flu vaccine
The U.S. Department of Health and Human Services announced it will award $590 million to Moderna to accelerate the development of influenza vaccines, including to protect against bird flu.